EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Interaction between lncRNAs and RNA binding proteins, and their potential as drug targets in the therapy of liver cancer (Review)

Jiawei Liu, Dong Chen

Biomedical Reports · 21.05.2026 · 25 (1) · 1-14

DOI: 10.3892/br.2026.2161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomedical Reports, online erschienen am 21.05.2026. Verfasst von Jiawei Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer, including hepatocellular carcinoma (HCC) as the major type, is a serious malignant tumor with high morbidity and mortality worldwide. Long noncoding RNAs (lncRNAs) play an essential role in the pathogenesis and development of liver cancer, as they can cooperate with and modulate other molecules, particularly RNA binding proteins (RBPs), to perform regulatory functions. Conversely, RBPs also deeply influence the functional manner of lncRNAs in cancer cells. Thus, it is critical to decipher how lncRNAs and RBPs interact with each other, affect the expression, localization, structure, modification, or function of their partners, and induce the following biological programs. In the present review, the interactions between lncRNAs and RBPs identified over the past years are examined, and their modes of cooperation and downstream effects on liver cancer progression are explored. Briefly, lncRNA-RBP pairs were classified into different categories according to their mechanisms of interaction and their influence on liver cancer development, including how their interactions affect one another, how they cooperate to regulate targets, and the resulting functional outcomes on liver cancer. In addition, the current state-of-the-art databases and technologies used to identify potential interactions between lncRNAs and RBPs were also emphasized, including crosslinking and immunoprecipitation, RNA immunoprecipitation, RNA pull-down and mass spectrometry. In summary, the present review systematically summarized the regulatory functions of lncRNA-RBP pairs in liver cancer, which suggests the potential to harness RNA-based therapeutics as an alternative treatment modality for liver cancer.

Schlagwörter

Stichwörter der Autor:innen

RNA binding proteinsfunctional mannerliver cancerlong noncoding RNAs

Autor:innen und Institutionen

  • Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
  • Center for Genome Analysis, Wuhan Ruixing Biotechnology, Co., Ltd., Wuhan, Hubei 430074, P.R. China.

Zitieren

APA

Liu, J., & Chen, D. (2026). Interaction between lncRNAs and RNA binding proteins, and their potential as drug targets in the therapy of liver cancer (Review). Biomedical Reports, 25(1), 1-14. https://doi.org/10.3892/br.2026.2161

Vancouver

Liu J, Chen D. Interaction between lncRNAs and RNA binding proteins, and their potential as drug targets in the therapy of liver cancer (Review). Biomedical Reports. 2026;25(1):1-14. doi:10.3892/br.2026.2161

BibTeX
@article{Liu2026,
  author = {Liu, Jiawei and Chen, Dong},
  title = {Interaction between lncRNAs and RNA binding proteins, and their potential as drug targets in the therapy of liver cancer (Review)},
  journal = {Biomedical Reports},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {1--14},
  doi = {10.3892/br.2026.2161}
}
Kostenlos starten →